Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 1416

BillFederalSenateFloor Consideration
A bill to amend the Federal Trade Commission Act to prohibit anticompetitive behaviors by drug product manufacturers, and for other purposes.
About This Bill
Floor Vote
Latest Action · June 28, 2019
Placed on Senate Legislative Calendar under General Orders. Calendar No. 132.
Introduced
May 9, 2019
Cosponsors (13)
5D 7R
View PDF ↗

Public Comments (0)

No comments yet. Be the first to weigh in from the Take Action box.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.